Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01HBS
|
|||
| Former ID |
DNC009009
|
|||
| Drug Name |
Cyclohexylcarbamic acidbiphenyl-3-yl ester
|
|||
| Synonyms |
CHEMBL431202; biphenyl-N-cyclopentyl-carbamate; 546141-07-5; URB524; URB-524; cyclohexylcarbamic acidbiphenyl-3-yl ester; SCHEMBL530169; 3-Biphenylyl cyclohexylcarbamate; biphenyl-3-yl-cyclohexylcarbamate; biphenyl-3-yl cyclohexylcarbamate; ZINC3816417; BDBM50128585; AKOS015909861; KB-48012; Cyclohexyl-carbamic acid biphenyl-3-yl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H21NO2
|
|||
| Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C19H21NO2/c21-19(20-17-11-5-2-6-12-17)22-18-13-7-10-16(14-18)15-8-3-1-4-9-15/h1,3-4,7-10,13-14,17H,2,5-6,11-12H2,(H,20,21)
|
|||
| InChIKey |
KGKDDSYRBQOMLE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.